|
|
ICOS has more plans for Cialis
ICOS Corp will test its successful erectile dysfunction drug this summer to see if it helps treat people with a serious heart and lung disease, officials said Thursday. The announcement came as ICOS reported a $46.4 million loss for the first quarter. That loss amounted to 73 cents a share, missing most analysts' forecasts of 67 to 68 cents a share. Viagra.
Read more about ICOS has more plans for Cialis
Generic Viagra Articles
Back to articles
|
|